Correlation Between Design Therapeutics and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and AN2 Therapeutics, you can compare the effects of market volatilities on Design Therapeutics and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and AN2 Therapeutics.
Diversification Opportunities for Design Therapeutics and AN2 Therapeutics
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Design and AN2 is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Design Therapeutics and AN2 Therapeutics
Given the investment horizon of 90 days Design Therapeutics is expected to generate 0.86 times more return on investment than AN2 Therapeutics. However, Design Therapeutics is 1.16 times less risky than AN2 Therapeutics. It trades about 0.01 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 1,350 in Design Therapeutics on August 27, 2024 and sell it today you would lose (788.00) from holding Design Therapeutics or give up 58.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Design Therapeutics vs. AN2 Therapeutics
Performance |
| Timeline |
| Design Therapeutics |
| AN2 Therapeutics |
Design Therapeutics and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and AN2 Therapeutics
The main advantage of trading using opposite Design Therapeutics and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |